Introduction
============

Nanoemulsions are isotropic dispersed systems with droplets that are between 20 and 200 nm in size.[@b1-ijn-9-4685]--[@b3-ijn-9-4685] Due to the size of their droplets, nanoemulsions are kinetically stable and resist sedimentation and creaming. They also possess a high level of kinetic stability and optical transparency.[@b4-ijn-9-4685]--[@b6-ijn-9-4685] Developing a nanoemulsion formula that involves a self-emulsifying system normally involves the combination of isotropic mixtures with an oil component and a surfactant in a specific ratio. When the correct ratio is used, the resulting compound will have the ability to form a nanoemulsion when dispersed with aqueous media and gently agitated.[@b7-ijn-9-4685]--[@b9-ijn-9-4685]

Self-emulsifying systems offer a strategy for dealing with the low oral bioavailability of drugs that are not easily dissolved in water.[@b10-ijn-9-4685],[@b11-ijn-9-4685] The size of the droplets in an emulsion is critical to the behavior of the self-emulsifying systems because droplet size determines the rate at and level to which a drug is released and absorbed.[@b12-ijn-9-4685]--[@b17-ijn-9-4685] Pharmaceutical formulas depend on the identification of a system that will spontaneously emulsify. The mechanism behind spontaneous emulsification with gentle agitation in an aqueous media such as gastrointestinal fluids is initiated when the change in entropy that favors dispersion is bigger than the force required to increase the surface area of the dispersed phase.[@b3-ijn-9-4685],[@b18-ijn-9-4685],[@b19-ijn-9-4685] Emulsification occurs spontaneously as a result of low and negative or positive free energy.

Self-emulsifying formula production involves combining oils and surfactants. The components used must be able to be taken orally, such as nonionic surfactants and oils with medium-chain triglyceride. Self-emulsifying systems impacted the concentration of surfactants and their hydrophilic/lipophilic balance (HLB).[@b20-ijn-9-4685],[@b21-ijn-9-4685]

*Swietenia* oil is extracted from the plant seeds of *Swietenia macrophylla*, which is a member of the family Meliaceae.[@b22-ijn-9-4685] It is grown widely in the Pacific region and in more than 40 countries in Southern Asia.[@b22-ijn-9-4685]--[@b24-ijn-9-4685] *S. macrophylla* seeds are collected from its fruit ("sky fruit").[@b24-ijn-9-4685] The *S. macrophylla* tree has a variety of medicinal properties and it is used in the treatment of hypertension, cancer, diabetes, malaria, chest pains, intestinal parasites, and amebiasis.[@b25-ijn-9-4685],[@b26-ijn-9-4685] It also has antifungal, antibacterial,[@b27-ijn-9-4685],[@b28-ijn-9-4685] antinociceptive,[@b29-ijn-9-4685] antimicrobial,[@b30-ijn-9-4685] and antidiarrheal properties.[@b31-ijn-9-4685]

Materials and methods
=====================

Materials
---------

The *Swietenia* oil used in this study was obtained from Nawa Pharma Sdn Bhd (Malaysia). Tween 20 (polyoxyethylene sorbitan monolaurate) was a product of Sigma-Aldrich Co. (St Louis, MO, USA). Labrafil^®^ M1944CS (oleoyl macrogol-6 glycerides) and Labrasol^®^ (caprylocaproyl macrogol-8 glycerides) were purchased from Gattefosse SAS (France) and Capmul^®^ MCM C8 (glyceryl monocaprylate) was purchased from Abitec Corporation (USA).

Methods
-------

### Preparation of self-nanoemulsifying systems

Self-emulsifying systems were formulated by combining *Swietenia* oil with different surfactants and cosurfactants as described by Eid et al.[@b32-ijn-9-4685] Five different surfactant mixtures containing *Swietenia* oil were kept at a constant temperature and these formed the basis of ternary phase diagrams. System 1 was composed of a mixture of oil, Capmul/Labrasol (2:1), and Labrafil/Tween 20 (1:2). System 2 consisted of *Swietenia* oil, Capmul, and Tween 20. System 3 was a mixture of *Swietenia* oil, Labrafil, and Tween 20, whereas System 4 combined *Swietenia* oil, Capmul, and Labrasol. Finally, System 5 comprised a mixture of *Swietenia* oil, Labrafil, and Labrasol. These combinations were used to examine how emulsification was affected by different parameters.

Each formulation was prepared by weighing the *Swietenia* oil and surfactants with an analytical balance (Mettler Toledo) and based on a ternary phase diagram. The oil and surfactants were homogenized for 2 minutes by vortex mixer. Then, a sample was dispersed in distilled water under gentle agitation. The resulting emulsion droplet size was measured to find the efficient emulsification formula. All experiments were carried out in triplicate at a constant temperature (25°C).

Nanoemulsion areas were marked on the ternary phase diagrams to indicate transparency and the presence of fine droplets (\>1,000 nm). Areas of macroemulsion were also marked to indicate whiter, isotropic solutions that could contain micelle solutions (1--20 μm). Regions that were visibly cloudy indicated areas of coarse emulsion (20--100 μm).

### The size of the droplets, their distribution, and a zeta potential analysis

To observe the size and distribution of the droplets, a 250 μL sample of *Swietenia* oil and surfactant mixture was self-emulsified in 300 mL of distilled water. The mixture was gently agitated with a glass rod. The size and size distribution of the droplets were examined using a Mastersizer 2,000 particle size analyzer (Malvern Instruments, Malvern, UK) for the resulting emulsion. Size and distribution measurements were taken in triplicate. This step was part of the screening study of the ternary phase diagram. A Malvern Zetasizer Nano was used to perform a zeta potential analysis on formulations with droplets that were smaller than 200 nm.[@b32-ijn-9-4685]

### Visual observation

The emulsification process and the tendency of the formulas to emulsify spontaneously were observed by self-emulsification when dispersing at a 250 μL sample of an oil/surfactants mixture in 300 mL of distilled water. A glass rod was used to gently agitate the mixture. A good emulsion was reflected by droplets that self-emulsified easily in distilled water and produced a fine milky emulsion. A moderate emulsion required longer to emulsify and produced a milky emulsion. A poor emulsion or no emulsion is considered to be formed when the oil droplets immediately coalesce. In this study, the ability of the emulsion to spread, mix, and easily disperse in distilled water was observed. The time to emulsification represented the length of time required for the formula to emulsify.

### Self-nanoemulsifying formulations' viscosity

A Brookfield viscometer (Wingather 2.1 software) was used to measure the viscosity of self-nanoemulsifying formulations at 25°C±1°C. A 31s-sized spindle was used. The spindle speed began at 40 rpm and increased in 10 rpm increments every minute until 120 rpm was reached. The viscosity, in centipoises (cP), was calculated by multiplying the density of the sample with the resulting value.[@b32-ijn-9-4685]

### In vivo anti-inflammatory study

The technique proposed by Winter et al[@b33-ijn-9-4685] was used to evaluate the anti-inflammatory properties of each mixture. Forty-eight hours before the beginning of the experiment, 60 male Sprague Dawley rats were randomly selected. Each rat weighed between 180 and 200 g. The guidelines developed by Universiti Teknologi MARA for the care of laboratory animals and the ethical standards for investigating pain conscious animals were followed for the duration of this study. The rats were kept at room temperature (25°C±2°C) with 60%--70% humidity and a 12-hour light/darkness cycle in the animal holding unit. A sample of 0.1 mL of a 1% suspension of carrageenan and saline was injected in the subplantar region of the right hind paw of each rat to cause edema.

The rats were divided into ten groups of six rats. The first four groups were injected with different concentrations of *Swietenia* oil solution (0.5, 1, 2, and 4 mL/kg). The fifth, sixth, seventh, and eighth groups received a self-nanoemulsifying formulation containing *Swietenia* oil in different concentrations (0.5, 1, 2, and 4 mL/kg). The ninth group acted as a positive control group. Each member of the ninth group received 200 mg/kg of acetylsalicylic acid. The tenth group was injected with saline and they served as a negative control in this experiment.

Sixty minutes after injection of either a *Swietenia* oil solution, a self-nanoemulsifying formulation, or acetylsalicylic acid, all the rats received an injection of carrageenan. Paw volumes were measured every hour for the next 4 hours using a digital paw edema meter (520-R; IITC Life Science, USA).[@b34-ijn-9-4685],[@b35-ijn-9-4685] The amount of swelling caused by the carrageenan injections at the specified intervals was calculated as a percentage of difference in the mean paw thickness before and after the carrageenan injection divided by the initial thickness of the paw, as shown below: $$\%\ \text{change~of~hind~paw~volume} = (\lbrack\text{mean~Cn} - \text{mean~Ci}\rbrack/\text{mean~Ci}) \times 100,$$

where Ci is the initial volume of the hind paw and Cn is the hind paw volume at specific intervals following the carrageenan injection.[@b36-ijn-9-4685]--[@b38-ijn-9-4685]

Statistical analysis
--------------------

A one-way analysis of variance (ANOVA) was used to statistically analyze the anti-inflammatory effects. *P*\<0.05 indicated a statistically significant difference.

Results and discussion
======================

After several different mixtures of *Swietenia* oil and surfactants were prepared, they were examined for their self-emulsification abilities when they were subjected to gentle agitation in water. [Figures 1](#f1-ijn-9-4685){ref-type="fig"}--[5](#f5-ijn-9-4685){ref-type="fig"} show the ternary phase diagrams of *Swietenia* oil with different surfactant/cosurfactant mixtures. The different areas in each ternary diagram represent isotropic emulsion, transparent emulsion, separation emulsion, and coarse emulsion.

System 1 ([Figure 1](#f1-ijn-9-4685){ref-type="fig"}) consisted of *Swietenia* oil and four different surfactant/cosurfactant mixtures. Those mixtures produced the largest nanoemulsion region compared to the other ternary phase diagrams. This large region of nanoemulsion was explained by the presence of different surfactant mixtures that facilitated the preparation of many series of formulations and led to the development of nanoemulsion formulas with enhanced stability. Moreover, [Figures 2](#f2-ijn-9-4685){ref-type="fig"} and [3](#f3-ijn-9-4685){ref-type="fig"} (ternary phase diagrams) show moderate levels of emulsification. The areas of nanoemulsion were smaller in the corresponding formulations, and these formulations did not remain stable overnight. Ternary phase diagrams are shown in [Figures 4](#f4-ijn-9-4685){ref-type="fig"} and [5](#f5-ijn-9-4685){ref-type="fig"}. The two corresponding formulations had poor nanoemulsion as they produced only macroemulsions.

The ternary phase diagram for System 1 shows nanoemulsions produced with oil concentrations between 20% and 50% and mixed with different concentrations of Capmul/Labrasol at a ratio of 2:1 and Labrafil/Tween 20 at a ratio of 1:2. This suggests a maximum oil concentration and a minimum surfactants concentration. Mixing different surfactants yielded better self-nanoemulsifying systems with nano-size droplets below 200 nm.

Combining different types of surfactants/cosurfactants contributed to more accurate results compared to the results of using only a single surfactant. The nanoemulsion region in the ternary phase diagram of System 1 was greatly increased and the oil concentrations were broader as different amounts of oil was used in each formulation. Pouton[@b39-ijn-9-4685] reported that, when developing a self-emulsifying formula, choosing the surfactants with the right combination of high and low HLBs is critical to the successful formulation of a microemulsion. Surfactants with high HLB values have excellent spreading and rapid self-emulsification properties. On the other hand, low HLB surfactants display poor spreading characteristics, poor self-emulsifying properties, and long emulsification times.

The surfactant selection is important in achieving the optimum self-nanoemulsifying formulation. Each oil and surfactant has a specific HLB. The right selection of surfactant or surfactant mixture HLB value that matches the selected oil HLB value will help in achieving the water and oil phases with the lowest interface tension. Self-emulsifying systems are extremely sensitive to the ratio of oils to surfactants/cosurfactants in the mixture. In the ternary phase diagram of System 1, Tween 20 shows a high HLB value. It was chosen as a nonionic surfactant because it produced superior self-emulsifying systems with faster emulsification times and fine oil-in-water droplets. Combining Labrafil (HLB 4) and Tween 20 (HLB 16.7) at a 1:2 ratio enhanced the self-emulsification properties. Used alone, Tween 20 has high hydrophilic groups that produce an immiscible oil/surfactant mixture and will cause poor self-emulsification properties in the resulting product if very hydrophobic oils are used. In this study, Labrafil was added to improve the self-emulsification properties of the system and make it more stable.

Combining Capmul (HLB 5--6) and Labrasol (HLB 14) at a ratio of 2:1 also facilitated the solubility of hydrophobic oil components to create a stable self-emulsifying system. A combination of Capmul and Labrasol was used in System 4, while in System 5, a mixture of Labrafil and Labrasol. These two combinations resulted in a ternary phase diagram with a large region of macroemulsion and no nanoemulsion region, indicating that these combinations did not produce nanoemulsion, but would be suitable for self-macroemulsion formulations. These results are supported by Gao and Morozowich,[@b40-ijn-9-4685] who maintained that high HLB values of nonionic surfactants in self-emulsifying drug delivery systems demonstrated the immediate formation of oil-in-water droplets and that the formula rapidly spread in aqueous media. These systems were also very stable.

System 2 combined Capmul and Tween 20 and System 3 combined Labrafil and Tween 20. Both systems exhibited the ability to produce nanoemulsions. This indicates that Tween 20 was a good nonionic surfactant and that it is suitable for producing a self-nanoemulsion system because it possesses good solubility properties. When Tween 20 was not added to a system, poor nanoemulsions were produced, as shown in Systems 2 and 3. Additionally, when surfactants with high HLB values (Labrasol) were used to prepare self-emulsifying systems, the performance of those systems was worse if Tween 20 was not added. Only the right mixture of surfactants will produce a suitable self-nanoemulsion system. Mahdi et al[@b41-ijn-9-4685] experienced similar results with blends containing nonionic surfactants Tween and Tween/Span^®^, which had been screened with water for their solubilization capability for palm kernel oil esters. Mahdi et al's[@b41-ijn-9-4685] results confirmed that the solubilizing capacity of Tween 20 is higher compared to other surfactants; in addition, high HLB blends of surfactants and cosurfactants have better solubility properties compared to blends with lower HLB values.

*Swietenia* oil and surfactant blends' behavior on droplet size, size distribution, and zeta potential
------------------------------------------------------------------------------------------------------

To categorize where emulsion formation occurred, *Swietenia* oil and surfactants/cosurfactants mixtures were studied for their droplet size and size distribution. It was revealed in the ternary phase diagrams that the droplet sizes were different when different combinations of surfactants/cosurfactants were used. In a comparison of the ternary phase diagrams, System 1 had the finest droplet size and size distribution. The smallest droplet size produced by *Swietenia* oil was 111±1.4 nm, with size distribution 0.177±0.007. By comparison, System 2 had droplets that were 231±2.6 nm in size with size distribution 1.02±0.006, and the droplets in System 3 were 189±1.7 nm in size with size distribution 0.469±0.009. Systems 4 and 5 had the largest droplets. In System 4, droplet size was 1.07±2.8 μm with size distribution 1.632±0.004 and, in System 5, the droplets were 1.103±2.3 μm in size with size distribution 0.547±0.008.

[Table 1](#t1-ijn-9-4685){ref-type="table"} sets out the compositions of the self-nanoemulsifying formulations from System 1, the size of their droplets, and their size distribution. Droplet size and size distribution were measured using a Malvern Mastersizer instrument. The Malvern Mastersizer instrument allows for measurements from nm to μm. Formulations with droplet sizes that were less than 200 nm were selected. As shown in [Table 1](#t1-ijn-9-4685){ref-type="table"}, formulations A, B, and E produced the smallest and most uniform droplet sizes compared to other self-nanoemulsifying formulations with the same oil concentration of 20%. Formulation I also had small droplets (116±1.6 nm) and a size distribution of 0.117±0.007 in the presence of high oil concentrations (50%). Overall, formulation I would be the best formula to use in a self-nanoemulsifying formulation.

Overall, the ternary phase diagrams demonstrate that, when there is an increase in the oil content in the formulations, the size of the droplets and the speed of self-emulsification also increased. However, the presence of a large amount of oil meant that the formulation quickly separated, indicating that this would not be stable after self-emulsification. This can be explained by the decrease in the amount of surfactants available for adsorption and a film that formed at the oil--water interface. Similar results were reported by Zhao et al[@b43-ijn-9-4685] who investigated a self-nanoemulsifying drug delivery system using zedoary essential oil in an oral delivery system. Zhao et al[@b43-ijn-9-4685] found that the size of the droplets gradually decreased from 180 nm until they reached 38 nm in size when the surfactant content rose from 30% to 75%. They suggested that the decrease in droplet size was due to the existence of more surfactant at the oil--water interface that increased the stability of emulsions with nano-size droplets.

Zeta potential is the potential between the surface of a droplet and the dispersing liquid. It will vary based on the distance between the droplet surface and the ion. The zeta potential for optimum formulations was measured using a Malvern Zetasizer. In general, emulsions with positive or negative potentials of more than 30 mV were considered to be stable.[@b42-ijn-9-4685] The zeta potential for the formulations in this study ranged between −21.8 and −34.4. Formulation I had the best zeta potential (−34.4), indicating that it was more stable than any of the other formulations.

*Swietenia* oil and surfactants mixtures' behavior on appearance and emulsification time of self-nanoemulsifying formulations
-----------------------------------------------------------------------------------------------------------------------------

A visual examination of the self-nanoemulsifying formulations revealed that they were transparent and yellowish in color. When the oil content was increased, the formulations became more yellow and the time of emulsification was reduced. Zhao et al[@b43-ijn-9-4685] found that emulsification time is affected by the increase in the surfactant concentration. These authors stated that, when there is an increase from 30% to 75% of the surfactant concentration, the time of emulsification rose from 1 to 5 minutes. Similar conclusions were also reported by Gao et al[@b44-ijn-9-4685] who confirmed that emulsification times will increase as the surfactant concentration increases.

System 1 showed a moderate time of emulsification, at around 25--130 seconds, then the time of emulsification was around 20--110 seconds for Systems 2 and 3, and, lastly, emulsification time was around 25--125 seconds for Systems 4 and 5. [Table 2](#t2-ijn-9-4685){ref-type="table"} presents the results of a visual examination of the *Swietenia* oil self-nanoemulsifying formulations from System 1. [Table 2](#t2-ijn-9-4685){ref-type="table"} reveals that all formulations possessed different emulsification times with good spreading properties. Formulations A, B, E, G, and J took 42--58±0.5 seconds to emulsify, while C, F, and H self-nanoemulsifying formulations showed moderate emulsification times (29--37±0.5 seconds). Formulations D and I had the fastest emulsification times, at 27 and 28±0.5 seconds, respectively.

The ratio of oil to surfactants will influence the self-emulsifying properties, which are required to produce formulations with nano-size droplets. Conversely, emulsification times are adversely affected by surfactant concentrations. These findings are in agreement with earlier studies that showed similar relationships between the emulsification times and the various concentrations of oil and surfactant mixtures. For example, Buyukozturk et al[@b45-ijn-9-4685] revealed a strong relationship between the mean droplet size of emulsions which contained surfactants with high levels of HLB and the changes in the oil-to-surfactant ratio. Bachynsky et al[@b46-ijn-9-4685] found that the self-emulsification properties are affected even with low amounts of oil in the system. Craig et al[@b47-ijn-9-4685] reported that formulations with good self-emulsification properties were significantly influenced by the concentration of oil, mentioning that formulations with good self-emulsification properties also have the ability to form clouds within 60 seconds with good spreading characteristics.

On the other hand, when the ratio of surfactants increases, the self-emulsifying process becomes difficult. The viscosity of the formulation would be increased with the increase in surfactant content, thus leading to a longer emulsification time. Emulsification times depend on the chemical structure of an oil and the proportions of oil, surfactants, and cosurfactants in the mixture. This study revealed that emulsification time was reversely affected by the concentrations of surfactants and cosurfactants in a mixture. When the amount of oil in a formulation was increased from 20% to 50%, it meant that the concentration of surfactants and cosurfactants were decreased and emulsification times also increased (from 27 to 58 seconds). Overall, the emulsification time for each formulation was good, as each one formed a cloud in less than 60 seconds.

Self-nanoemulsifying formulations' viscosity
--------------------------------------------

The viscosities of self-nanoemulsifying formulations that consisted of oil and surfactants are reported in [Table 3](#t3-ijn-9-4685){ref-type="table"}. At ambient temperature, self-nanoemulsifying formulations were viscous. The viscosity ranged from as low as 102±3.9 cP to as high as 143±2.7 cP. Formulation A was the most viscous formulation, with a viscosity of 143.1±2.7 cP, followed by formulation B, with a viscosity of 139.7±3.2 cP. Formulation D had the lowest viscosity (102.1±3.9 cP).

[Table 3](#t3-ijn-9-4685){ref-type="table"} illustrates that different self-nanoemulsifying formulations have different viscosity values. The viscosity properties and flow of self-nanoemulsifying formulations were affected by the different concentrations of oil and surfactants used. This phenomenon is demonstrated by the decrease in oil concentration and the increase in the concentrations of surfactants, showing that a high concentration of oil resulted in low viscosity values. Increased viscosity could require greater shear forces for dispersion and mean that the formulation would take a longer time to emulsify. In this study, all the formulations achieved self-emulsification with gentle agitation. In addition, the time of emulsification was influenced by the ratio of oil to surfactants. Self-emulsifying formulations having low viscosity required a short time of emulsification compared to those formulations with higher viscosity.

Anti-inflammatory activity of *Swietenia* oil self-nanoemulsifying systems
--------------------------------------------------------------------------

The present study investigated the anti-inflammatory activity of *Swietenia* oil. The anti-inflammatory properties of *Swietenia* oil solutions, formulations of different concentrations (0.5, 1, 2, and 4 mL/kg), aspirin (200 mg/kg) (used as a positive control), and negative control were compared using carrageenan injected into the paws of 60 rats to induce edema. The effect of *Swietenia* oil solution on carrageenan-induced paw edema in rats is shown in [Figure 6](#f6-ijn-9-4685){ref-type="fig"}, where a significant difference in the percentages of anti-inflammatory activity can be observed after 1, 2, 3, and 4 hours (*P*\<0.05).

The highest level of anti-inflammatory action was seen in rats treated with 4 mL/kg of *Swietenia* oil (54%). As shown in [Table 4](#t4-ijn-9-4685){ref-type="table"}, these results were better than those of any other formulation except for aspirin, which had a 71.5% inhibition effect, making it significantly more effective than the 4 mL/kg of *Swietenia* oil.

The anti-inflammatory effectiveness of *Swietenia* oil at different concentrations (0.5, 1, 2, and 4 mL/kg) in the form of a self-nanoemulsifying formulation over a period of 4 hours was almost as high as that of aspirin ([Figure 7](#f7-ijn-9-4685){ref-type="fig"}). The highest level of anti-inflammatory activity was observed with dosages of 4 mL/kg with a mean inhibition of 76.4%. This was followed by a 2 mL/kg dose (74.5%). These findings are significantly higher than the anti-inflammatory effect of a 200 mg/kg dosage of aspirin. The inhibition activity of *Swietenia* oil self-nanoemulsifying formulations (0.5 mL/kg and 1 mL/kg) was 64.5% and 68.9%, respectively, as shown in [Table 5](#t5-ijn-9-4685){ref-type="table"}.

The results depicted in [Table 5](#t5-ijn-9-4685){ref-type="table"} demonstrate that there are significant differences in the anti-inflammatory properties of different *Swietenia* oil preparations compared to the same concentrations of oil in the form of solution and in self-nanoemulsifying formulations. The effect was higher in self-nanoemulsifying systems, and this may be explained by the presence of smaller droplets that would increase the absorption of *Swietenia* oil.

Conclusion
==========

*Swietenia* oil self-nanoemulsifying formulations were prepared successfully by blending the oil with different types of surfactants. The self-nanoemulsifying systems were sensitive to the oil/surfactants ratios and the properties of the surfactants phase. The self-nanoemulsifying formulations were significantly improved and had better self-nanoemulsifying properties when Tween 20 was added to the surfactants mixture. Adding Tween 20 as a hydrophilic surfactant (20%--50%) to the formulations reduced the size of the oil droplets. Emulsification times increased when more hydrophilic surfactant was added to the formulation because of the high viscosity of the hydrophilic surfactant. Emulsification times were faster when there was an increase in the formulation's oil content, but this led to poor self-nanoemulsifying systems with larger oil droplets, and the mixture separated after a few minutes. The *Swietenia* oil solution had less anti-inflammatory activity when compared to the positive control, but the anti-inflammatory activity of *Swietenia* oil improved when the oil was applied in the form of self-nanoemulsifying systems, as it exhibited higher anti-inflammatory activity compared to the positive controls.
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###### 

Self-nanoemulsifying formulations of *Swietenia* oil in System 1

  Formulation   Labrafil^®^/Tween 20 (%)   Capmul^®^/Labrasol^®^ (%)   *Swietenia* oil (%)   Droplet size (nm) ± SD   Size distribution ± SD   Zeta potential (mV)
  ------------- -------------------------- --------------------------- --------------------- ------------------------ ------------------------ ---------------------
  A             32.0                       48.0                        20.0                  118±1.7                  0.283±0.007              −26.3
  B             40.0                       40.0                        20.0                  119± 1.6                 0.267±0.004              −28.6
  C             32.0                       32.0                        36.0                  133±1.9                  0.371±0.009              −26.4
  D             40.0                       10.0                        50.0                  184±1.1                  0.293±0.006              −23.3
  E             48.0                       32.0                        20.0                  111±1.4                  0.260±0.008              −28.9
  F             38.4                       25.6                        36.0                  146±1.2                  0.255±0.005              −28.2
  G             56.0                       24.0                        20.0                  126±1.7                  0.339±0.009              −21.8
  H             44.8                       19.2                        36.0                  151±1.3                  0.387±0.004              −23.3
  I             35.0                       15.0                        50.0                  116±1.6                  0.177±0.007              −34.4
  J             64.0                       16.0                        20.0                  169±1.8                  0.335±0.005              −33.0

**Note:** n=3.

**Abbreviation:** SD, standard deviation.

###### 

Visual characteristics of *Swietenia* oil self-nanoemulsifying formulations

  Formulation   Spreadability   Time (s) ±0.5   Appearance
  ------------- --------------- --------------- ----------------------------------
  A             Spreadable      45              Transparent emulsion
  B             Spreadable      42              Transparent emulsion
  C             Spreadable      35              Transparent emulsion
  D             Spreadable      27              Transparent (yellowish) emulsion
  E             Spreadable      48              Transparent emulsion
  F             Spreadable      29              Transparent emulsion
  G             Spreadable      57              Transparent emulsion
  H             Spreadable      37              Transparent emulsion
  I             Spreadable      28              Transparent (yellowish) emulsion
  J             Spreadable      58              Transparent emulsion

**Note:** n=3.

###### 

Viscosity values of *Swietenia* oil self-nanoemulsifying formulations

  Formulation   Labrafil^®^/Tween 20 (%)   Capmul^®^/Labrasol^®^ (%)   *Swietenia* oil (%)   Viscosity (cP) ± SD
  ------------- -------------------------- --------------------------- --------------------- ---------------------
  A             32.0                       48.0                        20.0                  143.1±2.7
  B             40.0                       40.0                        20.0                  139.7±3.2
  C             32.0                       32.0                        36.0                  120.7±4.5
  D             40.0                       10.0                        50.0                  102.1±3.9
  E             48.0                       32.0                        20.0                  135.7±3.1
  F             38.4                       25.6                        36.0                  112.3±3.5
  G             56.0                       24.0                        20.0                  132.9±2.6
  H             44.8                       19.2                        36.0                  111.3±3.8
  I             35.0                       15.0                        50.0                  109.1±4.1
  J             64.0                       16.0                        20.0                  130.4±3.2

**Note:** n=3.

**Abbreviations:** cP, centipoises; SD, standard deviation.

###### 

Changes in rat hind paw volume and the percentage of inhibition of *Swietenia* oil solutions at different oil concentrations

  Paw volume (mL)                                                                             
  --------------------- --- --------------------- --------------------- --------------------- ---------------------
  0.5 ml/kg             0   0.098±0.031 (13.3%)   0.137±0.021 (24.7%)   0.165±0.027 (24.3%)   0.158±0.029 (21%)
  1 ml/kg               0   0.083±0.029 (26.5%)   0.108±0.032 (40.7%)   0.125±0.043 (42.7%)   0.106±0.035 (45%)
  2 ml/kg               0   0.082±0.031 (28.3%)   0.105±0.022 (42.3%)   0.123±0.023 (43.6%)   0.102±0.029 (49.5%)
  4 ml/kg               0   0.077±0.015 (32.7%)   0.103±0.012 (43.4%)   0.121±0.011 (44.5%)   0.092±0.018 (54%)
  Aspirin (200 mg/kg)   0   0.065±0.027 (42.5%)   0.095±0.031 (47.8%)   0.067±0.02 (69.3%)    0.057±0.019 (71.5%)
  Negative control      0   0.113±0.029 (−)       0.182±0.030 (−)       0.218±0.041 (−)       0.203±0.031 (−)

**Notes:** Values are mean ± standard deviation. n=6 animals in each group.

**Abbreviation:** h, hours.

###### 

Changes in rat hind paw volume and the percentage of inhibition of self-emulsifying formulations of *Swietenia* oil at different oil concentrations

  Paw volume (mL)                                                                             
  --------------------- --- --------------------- --------------------- --------------------- ---------------------
  0.5 ml/kg             0   0.082±0.029 (27.4%)   0.102±0.025 (43.9%)   0.08±0.015 (62.5%)    0.072±0.072 (64.5%)
  1 ml/kg               0   0.078±0.010 (30.9%)   0.097±0.020 (46.7%)   0.07±0.017 (67.9%)    0.063±0.018 (68.9%)
  2 ml/kg               0   0.058±0.018 (48.7%)   0.082±0.035 (54.9%)   0.063±0.019 (71.1%)   0.052±0.012 (74.4%)
  4 ml/kg               0   0.055±0.016 (51.3%)   0.07±0.02 (60.4%)     0.06±0.017 (72.3%)    0.048±0.018 (76.4%)
  Aspirin (200 mg/kg)   0   0.065±0.027 (42.5%)   0.095±0.031 (47.8%)   0.067±0.020 (69.3%)   0.057±0.018 (71.5%)
  Negative control      0   0.113±0.029 (−)       0.182±0.030 (−)       0.218±0.041 (−)       0.203±0.031 (−)

**Notes:** Values are mean ± standard deviation. n=6 animals in each group.

**Abbreviation:** h, hours.
